The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ

Revue Neurologique

Volumn 169, Issue 8-9, 2013, Pages 640-649

  Weiss, J M ^a   Cufi, P ^a   Le Panse, R ^a   Berrih Aknin, S ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Autoimmune; Gravis; Interferons dsRNA signaling; Myasthenia; Tertiary lymphoid neogenesis; Thymus

Indexed keywords

CHEMOKINE;

ANTIGEN PRESENTING CELL; ARTICLE; CELL INFILTRATION; CLINICAL FEATURE; IMMUNE RESPONSE; LYMPHOCYTE; LYMPHOID ORGAN; MYASTHENIA GRAVIS; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; THYMUS DISEASE; VIRUS INFECTION;

AUTOIMMUNE MYASTHENIA GRAVIS; DSRNA SIGNALING; INTERFERONS; INTERFÉRONS; MYASTHÉNIE AUTOIMMUNE; NÉOGENÈSE LYMPHOÏDE TERTIAIRE; TERTIARY LYMPHOID NEOGENESIS; THYMUS; VOIE DE SIGNALISATION DE L'ARNDB;

ANIMALS; AUTOANTIBODIES; HUMANS; LYMPHOID TISSUE; MYASTHENIA GRAVIS; THYMUS GLAND; THYMUS HYPERPLASIA; VIRUS DISEASES;

EID: 84884586857     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2013.02.005     Document Type: Article

References (77)

1. A. Aissaoui, I. Klingel-Schmitt, J. Couderc, D. Chateau, F. Romagne, and F. Jambou Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis Ann Neurol 46 4 1999 559 567
2. F. Aloisi, and R. Pujol-Borrell Lymphoid neogenesis in chronic inflammatory diseases Nat Rev Immunol 6 3 2006 205 217
3. G. Badr, G. Borhis, D. Treton, and Y. Richard IFN{alpha} enhances human B-cell chemotaxis by modulating ligand-induced chemokine receptor signaling and internalization Int Immunol 17 4 2005 459 467
4. K. Balabanian, J. Couderc, L. Bouchet-Delbos, A. Amara, D. Berrebi, and A. Foussat Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus J Immunol 170 6 2003 3392 3400
5. A. Balandina, S. Lecart, P. Dartevelle, A. Saoudi, and S. Berrih-Aknin Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis Blood 105 2 2005 735 741
6. E. Beghi, C. Antozzi, A.P. Batocchi, F. Cornelio, V. Cosi, and A. Evoli Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients J Neurol Sci 106 2 1991 213 220
7. S. Berrih-Aknin, E. Morel, F. Raimond, D. Safar, C. Gaud, and J.P. Binet The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases Ann N Y Acad Sci 505 1987 50 70
8. S. Berrih-Aknin, N. Ruhlmann, J. Bismuth, G. Cizeron-Clairac, E. Zelman, and I. Shachar CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia Ann Neurol 66 4 2009 521 531
9. S. Berrih, E. Morel, C. Gaud, F. Raimond, H. Le Brigand, and J.F. Bach Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis Neurology 34 1 1984 66 71
10. J.M. Budde, C.D. Morris, A.A. Gal, K.A. Mansour, and J.I. Miller Jr. Predictors of outcome in thymectomy for myasthenia gravis Ann Thorac Surg 72 1 2001 197 202
11. A.S. Carr, C.R. Cardwell, P.O. McCarron, and J. McConville A systematic review of population based epidemiological studies in Myasthenia Gravis BMC Neurol 10 2011 46
12. P. Cavalcante, M. Barberis, M. Cannone, F. Baggi, C. Antozzi, and L. Maggi Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis Neurology 74 14 2010 1118 1126
13. P. Cavalcante, B. Serafini, B. Rosicarelli, L. Maggi, M. Barberis, and C. Antozzi Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus Ann Neurol 67 6 2010 726 738
14. G. Cizeron-Clairac, R. Le Panse, M. Frenkian-Cuvelier, A. Meraouna, F. Truffault, and J. Bismuth Thymus and Myasthenia Gravis: what can we learn from DNA microarrays? J Neuroimmunol 201-202 2008 57 63
15. M. Colombara, V. Antonini, A.P. Riviera, F. Mainiero, R. Strippoli, and M. Merola Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells J Immunol 175 10 2005 7021 7028
16. D. Csuka, M. Banati, C. Rozsa, G. Fust, and Z. Illes High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis Eur J Neurol 19 6 2012 842 846
17. P. Cufi, N. Dragin, J.M. Weiss, P. Martinez-Martinez, M.H. De Baets, and R. Roussin Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis Ann Neurol 73 2 2013 281 293
18. B. De Klerck, L. Geboes, S. Hatse, H. Kelchtermans, Y. Meyvis, and K. Vermeire Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis Arthritis Res Ther 7 6 2005 R1208 R1220
19. A.B. Debra Bryce Gardner, P. Bugelski, R. Sarisky, and B. Liang Anti-CXCL13 and anti-TNF{alpha} combination therapy in a mouse model of systemic lupus erythematosu FASEB J 22 2008 473
20. J. Derbinski, A. Schulte, B. Kyewski, and L. Klein Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self Nat Immunol 2 11 2001 1032 1039
21. T. Feferman, R. Aricha, K. Mizrachi, E. Geron, R. Alon, and M.C. Souroujon Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3 J Neuroimmunol 209 1-2 2009 87 95
22. T. Feferman, P.K. Maiti, S. Berrih-Aknin, J. Bismuth, J. Bidault, and S. Fuchs Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis J Immunol 174 9 2005 5324 5331
23. K.G. Flores, J. Li, and L.P. Hale B cells in epithelial and perivascular compartments of human adult thymus Hum Pathol 32 9 2001 926 934
24. N. Fujii, Y. Itoyama, T. Tabira, and Y. Kuroiwa Subsets of lymphoid cells in blood and thymus in myasthenia gravis. Monoclonal antibody analysis J Neuroimmunol 4 3 1983 151 159
25. Y. Fujii, J. Hashimoto, Y. Monden, T. Ito, K. Nakahara, and Y. Kawashima Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis J Immunol 136 3 1986 887 891
26. M. Giraud, C. Vandiedonck, and H.J. Garchon Genetic factors in autoimmune myasthenia gravis Ann N Y Acad Sci 1132 2008 180 192
27. G.S. Gronseth, and R.J. Barohn Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 55 1 2000 7 15
28. V. Guigou, D. Emilie, S. Berrih-Aknin, F. Fumoux, M. Fougereau, and C. Schiff Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the Vh and Vk families Clin Exp Immunol 83 2 1991 262 266
29. O. Higuchi, J. Hamuro, M. Motomura, and Y. Yamanashi Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis Ann Neurol 69 2 2011 418 422
30. M.E. Hill, H. Shiono, J. Newsom-Davis, and N. Willcox The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics J Neuroimmunol 201-202 2008 50 56
31. P. Hjelmstrom Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines J Leukoc Biol 69 3 2001 331 339
32. D.L. Hodge, D. Reynolds, F.M. Cerbán, S.G. Correa, N.S. Baez, and H.A. Young MCP-1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes Eur J Immunol 42 10 2012 2644 2654
33. R. Horuk Chemokine receptor antagonists: overcoming developmental hurdles Nat Rev Drug Discov 8 1 2009 23 33
34. Z. Johnson, M. Schwarz, C.A. Power, T.N. Wells, and A.E. Proudfoot Multi-faceted strategies to combat disease by interference with the chemokine system Trends Immunol 26 5 2005 268 274
35. K. Kakalacheva, M.A. Maurer, B. Tackenberg, C. Munz, N. Willcox, and J.D. Lunemann Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravis Ann Neurol 70 3 2011 508 514
36. R.E. Kohler, I. Comerford, S. Townley, S. Haylock-Jacobs, I. Clark-Lewis, and S.R. McColl Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis Brain Pathol 18 4 2008 504 516
37. I.L. Korn, and O. Abramsky Myasthenia gravis following viral infection Eur Neurol 20 6 1981 435-9U
38. S.L. Kunkel, and N. Godessart Chemokines in autoimmunity: from pathology to therapeutics Autoimmun Rev 1 6 2002 313 320
39. K.J. Laing, and C.J. Secombes Chemokines Dev Comp Immunol 28 5 2004 443 460
40. R. Le Panse, and S. Berrih Aknin Human myoid cells protect thymocytes from apoptosis Cell death and differentiation 12 2005 463 472
41. R. Le Panse, G. Cizeron-Clairac, J. Bismuth, and S. Berrih Aknin Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative Myasthenia Gravis patients and the role of CCL21 in thymic hyperplasia J Immunol 177 2006 7868 7879
42. R. Le Panse, G. Cizeron-Clairac, M. Cuvelier, F. Truffault, J. Bismuth, and P. Nancy Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis Ann N Y Acad Sci 1132 2008 135 142
43. M.I. Leite, M. Jones, P. Ströbel, A. Marx, R. Gold, and E. Niks Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status Am J Pathol 171 3 2007 893 905
44. C. Leprince, S. Cohen-Kaminsky, S. Berrih-Aknin, B. Vernet-Der Garabedian, D. Treton, and P. Galanaud Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis J Immunol 145 7 1990 2115 2122
45. S.X. Li, Z.L. Hu, and L.Q. Zeng [Ultrastructural study of the thymus in patients with myasthenia gravis] Zhonghua Nei Ke Za Zhi 32 5 1993 310 312
46. Y.J. Liu, G.D. Johnson, J. Gordon, and I.C. MacLennan Germinal centres in T-cell-dependent antibody responses Immunol Today 13 1 1992 17 21
47. S.A. Luther, T. Lopez, W. Bai, D. Hanahan, and J.G. Cyster BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis Immunity 12 5 2000 471 481
48. S.A. Luther, A. Bidgol, D.C. Hargreaves, A. Schmidt, Y. Xu, and J. Paniyadi Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis J Immunol 169 1 2002 424 433
49. R. Mantegazza, F. Baggi, P. Bernasconi, C. Antozzi, P. Confalonieri, and L. Novellino Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up J Neurol Sci 212 1-2 2003 31 36
50. A.P. Martin, E.C. Coronel, G. Sano, S.C. Chen, G. Vassileva, and C. Canasto-Chibuque A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21 J Immunol 173 8 2004 4791 4798
51. A. Melms, B.C. Schalke, T. Kirchner, H.K. Muller-Hermelink, E. Albert, and H. Wekerle Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients J Clin Invest 81 3 1988 902 908
52. A. Meraouna, G. Cizeron-Clairac, R.L. Panse, J. Bismuth, F. Truffault, and C. Tallaksen The chemokine CXCL13 is a key molecule in autoimmune Myasthenia Gravis Blood 108 2 2006 432 440
53. M. Meyer, A.K. Höls, B. Liersch, R. Leistner, K. Gellert, and B. Schalke Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus Ann Neurol 70 3 2011 515 518
54. N. Moulian, J. Bidault, F. Truffault, A.M. Yamamoto, P. Levasseur, and S. Berrih-Aknin Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody Blood 89 9 1997 3287 3295
55. Y. Nagane, K. Utsugisawa, D. Obara, M. Yamagata, and H. Tohgi Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis Muscle Nerve 27 5 2003 582 589
56. M.W. Nicolle Myasthenia gravis Neurologist 8 1 2002 2 21
57. I.P. Nieto, J.P. Robledo, M.C. Pajuelo, J.A. Montes, J.G. Giron, and J.G. Alonso Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases Ann Thorac Surg 67 6 1999 1568 1571
58. M. Okumura, M. Ohta, Y. Takeuchi, H. Shiono, M. Inoue, and K. Fukuhara The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer J Thorac Cardiovasc Surg 126 6 2003 1922 1928
59. G. Palestro, G. Tridente, F. Botto Micca, D. Novero, G. Valente, and L. Godio Immunohistochemical and enzyme histochemical contributions to the problem concerning the role of the thymus in the pathogenesis of myasthenia gravis Virchows Arch B Cell Pathol Incl Mol Pathol 44 2 1983 173 186
60. A. Pevzner, B. Schoser, K. Peters, N.C. Cosma, A. Karakatsani, and B. Schalke Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis J Neurol 259 3 2012 427 435
61. S. Poëa-Guyon, P. Christadoss, R. Le Panse, T. Guyon, M. De Baets, and A. Wakkach Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis J Immunol 174 10 2005 5941 5949
62. N.H. Ruddle Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development Immunol Res 2-3 1999 119 125
63. A. Saha, P. Batra, K.Y. Vilhekar, and P. Chaturvedi Post-varicella myasthenia gravis Singapore Med J 48 6 2007 e177 e180
64. W. Savino The thymus is a common target organ in infectious diseases PLoS Pathog 2 6 2006 e62
65. S. Schonbeck, F. Padberg, R. Hohlfeld, and H. Wekerle Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis J Clin Invest 90 1 1992 245 250
66. G.P. Sims, H. Shiono, N. Willcox, and D.I. Stott Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis J Immunol 167 4 2001 1935 1944
67. N. Sommer, N. Willcox, G.C. Harcourt, and J. Newsom-Davis Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells Ann Neurol 28 3 1990 312 319
68. R.K. Suniara, E.J. Jenkinson, and J.J. Owen An essential role for thymic mesenchyme in early T cell development J Exp Med 191 6 2000 1051 1056
69. K. Utsugisawa, Y. Nagane, and H. Tohgi Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with Myasthenia gravis Muscle Nerve 23 4 2000 507 513
70. K. Utsugisawa, Y. Nagane, S. Suzuki, and R. Kondoh Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis Muscle Nerve 36 1 2007 100 103
71. U.H. von Andrian, and T.R. Mempel Homing and cellular traffic in lymph nodes Nat Rev Immunol 3 11 2003 867 878
72. A. Wakkach, T. Guyon, C. Bruand, S. Tzartos, S. Cohen-Kaminsky, and S. Berrih-Aknin Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis J Immunol 157 8 1996 3752 3760
73. A. Wang, A.M. Fairhurst, K. Tus, S. Subramanian, Y. Liu, and F. Lin CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus J Immunol 182 7 2009 4448 4458
74. J.M. Weiss, P. Cufi, J. Bismuth, B. Eymard, E. Fadel, and S. Berrih-Aknin SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients Immunobiology 218 3 2013 373 381
75. Q. Xia, W.B. Liu, H.Y. Feng, Z.G. Chen, Y. Zhang, and X.T. He [Correlation between pathogenesis of myasthenia gravis and thymus mature dendritic cells] Zhonghua Yi Xue Za Zhi 88 47 2008 3349 3351
76. J. Zhang, S. Cohen-Kaminsky, and S. Berrih-Aknin Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis Hum Antibodies Hybridomas 6 4 1995 153 160
77. Y. Zheng, L.M. Wheatley, T. Liu, and A.I. Levinson Acetylcholine receptor alpha subunit mRNA expression in human thymus: augmented expression in myasthenia gravis and upregulation by interferon-gamma Clin Immunol 91 2 1999 170 177